USPTO serial 79148822
WELLMERA
Reviewed by CopyMark Law Group
Reg. 4745656Status 404
- Filing date
- Status date
- Registration date
- Jun 2, 2015
- Examiner
- CORWIN, KEVIN SCOTT
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with WELLMERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CH-4057 Basel, CH
CH-4057 Basel, CH
CH-4057 Basel, CH
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Lebow
1727 King StreetSuite 105Alexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Software, namely, software for providing information on pricing and reimbursement assessments in health economic and market access strategies and plans in the health care industry | SECTION 71 - CANCELLED | — |
| 035 | Advertising; commercial business management, and marketing and professional business consultancy; advertising products of third parties in the health care industry; business management, namely, marketing and professional consultation in pricing and reimbursement strategies for brands and products at all stages of lifecycle development; brand management for businesses; brand management for pharmaceutical and medical device companies; business management and consultation providing commercial and clinical commercial strategies and commercial strategies for the production of integrated evidence plans to support pricing, reimbursement and market access; commercial business management, namely, development of value strategies for internal communication with cross-functional teams and senior management of companies to facilitate internal decision making; commercial business management, namely, development of early pricing and reimbursement strategies for brands, product management consulting at all development stages, and licensing opportunities; commercial business management, namely, conducting of pricing and reimbursement landscape assessments; commercial business management, namely, conducting of competitor analyses and development of pathways for disease management for comparative effectiveness research planning; commercial business management, namely, development of payer objection handler documents identifying potential payer objections to product reimbursement and arguments to address them; preparation of briefing documents for payer advisory boards; commercial business management, namely, conducting qualitative small scale payer research for hypothesis generation and unbranded or branded payer message testing and validation; commercial business management, namely, providing placement for market access managers and directors; commercial business management, namely, development of health economics and outcomes research strategies to support internal communication with cross-functional teams and senior management to facilitate internal strategic decisions; commercial business management, namely, providing strategic support for the development of economic models; design and development of budget impact models; commercial business management, namely, development of actionable plans to support the value communication of a product; commercial business management, namely, planning, preparation, coordination and conducting of expert panels and advisory boards; planning and conducting of database-registry analyses | SECTION 71 - CANCELLED | — |
| 041 | Education and training services, namely, workshops and seminars in the field of branding, product valuation and pricing, healthcare, and economics; education and training services, namely, workshops and seminars in the field of design and facilitation of product value and strategy; workshops and seminars in the field of design and facilitation of product value; workshops and seminars in the field of economic strategies and support of health economic deliverables; workshops and seminars in the nature of training to instruct on planning, preparation, coordination and conducting of expert panels and advisory boards for presentations and briefing documents in the health care industry; training services in the field of facilitation of workshops with cross-functional teams and affiliates to develop and refine economic strategies and support the adaptation of health economic deliverables; and workshops and seminars in the field of cross-functional and regional applied health economics training | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design services relating thereto, namely, scientific and technological competitor analysis and developing pathways for disease management for competitive research planning, conducting qualitative payer research for hypothesis, testing and validation; design and development of computers and software; design and development of computers and software for third parties | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Wellmera AG
- Other trademarks owned by Wellmera AG
- Other trademarks owned by Wellmera AG
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named WELLMERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 8, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 24, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 25, 2022 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 23, 2022 | INPC | INVALIDATION PROCESSED | — |
| Aug 17, 2022 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 17, 2021 | C71T | CANCELLED SECTION 71 | — |
| Jun 2, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 26, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 30, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 25, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 25, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 2, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 2, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 17, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 25, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 25, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 25, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 25, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 9, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jan 23, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 23, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 23, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 23, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 19, 2014 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 19, 2014 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 19, 2014 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 19, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 19, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 19, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 16, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 30, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 30, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 30, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 29, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 22, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 16, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 11, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |